Isolated Limb Perfusion With Tumor Necrosis Factor α and Melphalan for Locally Advanced Soft Tissue Sarcoma: The Value of Adjuvant Radiotherapy

被引:0
|
作者
Katja M. J. Thijssens
Robert J. van Ginkel
Elisabeth Pras
Albert J. H. Suurmeijer
Harald J. Hoekstra
机构
[1] University Medical Center Groningen,Department of Surgical Oncology
[2] University Medical Center Groningen,Department of Radiation Oncology
[3] University Medical Center Groningen,Department of Pathology
来源
Annals of Surgical Oncology | 2006年 / 13卷
关键词
Sarcoma; Isolated limb perfusion; Radiotherapy; Tumor necrosis factor; Melphalan; Long-term results.;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:518 / 524
页数:6
相关论文
共 50 条
  • [21] Hyperthermic isolated limb perfusion with tumor necrosis factor-α and melphalan in advanced soft-tissue sarcomas:: Histopathological considerations
    Issakov, J
    Merimsky, O
    Gutman, M
    Kollender, Y
    Lev-Chelouche, D
    Abu-Abid, S
    Lifschitz-Mercer, B
    Inbar, M
    Klausner, JM
    Meller, I
    ANNALS OF SURGICAL ONCOLOGY, 2000, 7 (02) : 155 - 159
  • [22] Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-α and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological Considerations
    Josephine Issakov
    Ofer Merimsky
    Mordechai Gutman
    Yehuda Kollender
    Dina Lev-Chelouche
    Soubhi Abu-Abid
    Beatriz Lifschitz-Mercer
    Moshe Inbar
    Joseph M. Klausner
    Isaac Meller
    Annals of Surgical Oncology, 2000, 7 : 155 - 159
  • [23] Isolated limb perfusion for malignant melanoma and locally advanced soft tissue sarcoma
    Kettelhack, C.
    ZEITSCHRIFT FUR HERZ THORAX UND GEFASSCHIRURGIE, 2009, 23 (01): : 50 - 54
  • [24] Treatment of Locally Advanced Soft Tissue Sarcoma by Hyperthermic Isolated Limb Perfusion, Preoperative Radiotherapy and Surgery (PRS)
    Stevenson, M.
    Seinen, J.
    van Ginkel, R.
    van Leeuwen, B. L.
    Pras, B.
    Suurmeijer, A.
    Been, L. B.
    Hoekstra, H. J.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S31 - S31
  • [25] High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation
    Gutman, M
    Inbar, M
    LevShlush, D
    AbuAbid, S
    Mozes, M
    Chaitchik, S
    Meller, I
    Klausner, JM
    CANCER, 1997, 79 (06) : 1129 - 1137
  • [26] Isolated limb perfusion with high-dose tumor necrosis factor α and melphalan for Kaposi sarcoma
    Lev-Chelouche, D
    Abu-Abeid, S
    Merimsky, O
    Isakov, J
    Kollander, Y
    Meller, I
    Klausner, JM
    Gutman, M
    ARCHIVES OF SURGERY, 1999, 134 (02) : 177 - 180
  • [27] Isolated limb perfusion with cisplatin and doxorubicin for locally advanced soft tissue sarcoma of an extremity
    Eroglu, A
    Kocaoglu, H
    Demirci, S
    Akgül, H
    EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2000, 26 (03): : 213 - 221
  • [28] Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors
    Vrouenraets, BC
    Keus, RB
    Nieweg, OE
    Kroon, BB
    JOURNAL OF SURGICAL ONCOLOGY, 1997, 65 (02) : 88 - 94
  • [29] Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas
    Farre Alegre, Jose
    Duarte, Maritza
    Sureda Gonzalez, Manuel
    Bretcha Boix, Pere
    Dussan, Carlos
    Ballester, Antonio
    Crespo, Aurora
    Brugarolas Masllorens, Antonio
    CIRUGIA ESPANOLA, 2012, 90 (02): : 114 - 120
  • [30] Treatment of recurrent sarcoma of the extremities by isolated limb perfusion using tumor necrosis factor alpha and melphalan
    Santinami, M
    Deraco, M
    Azzarelli, A
    Cascinelli, F
    Chiti, A
    Costagli, V
    Inglese, MG
    Manzi, R
    Quagliolo, V
    Rebuffoni, G
    Santoro, N
    Vaglini, M
    TUMORI, 1996, 82 (06) : 579 - 584